Medical Disclaimer
Please read this before using this Site
RetaWeightLoss.com (the "Site") publishes general information about retatrutide (LY3437943) and the research surrounding it. Everything on this Site is editorial and educational. It is not medical advice, and it is not an offer of any product or service.
1. This Site does not provide medical advice
The content on this Site is published for general information only. It is not a substitute for professional medical advice, diagnosis, or treatment, and it is not tailored to any individual's circumstances.
Nothing published here should be read as a recommendation to use, seek out, or avoid any medication.
Always seek the advice of a physician or other qualified health provider with any question you have about a medical condition or treatment. Never disregard professional medical advice, or delay seeking it, because of something you have read on this Site. Do not start, stop, or change any prescribed treatment on the basis of information published here.
2. No doctor–patient relationship
Using this Site does not create a doctor–patient relationship between you and RetaWeightLoss.com, its writers, or anyone associated with it. We are not a medical practice, we do not treat patients, and we do not provide medical services of any kind.
3. Retatrutide is investigational and is not available
Retatrutide is an investigational compound that has been studied in clinical trials. It is not approved by the U.S. Food and Drug Administration, or by any other regulatory authority, for any use.
This means:
- It cannot lawfully be prescribed, sold, dispensed, or purchased as a medicine.
- Its safety and efficacy have not been established outside of controlled clinical trials.
- We make no claim, prediction, or representation as to whether it will ever be approved, or when.
- Anything we publish reflects the trial data available at the time of writing and may be superseded.
We do not encourage anyone to attempt to obtain retatrutide. Products offered for sale online under that name are not approved medicines, are not subject to pharmaceutical manufacturing oversight, and may be adulterated, mislabeled, contaminated, or unsafe.
4. We are not affiliated with any manufacturer
RetaWeightLoss.com is an independent publication. We are not affiliated with, endorsed by, sponsored by, or otherwise connected to Eli Lilly and Company or to any other pharmaceutical manufacturer.
Retatrutide is an investigational drug developed by Eli Lilly and Company. All product names, trademarks, and registered trademarks referred to on this Site are the property of their respective owners and are used only to identify the compounds and research under discussion. Their use does not imply any affiliation, sponsorship, or endorsement.
5. We do not help anyone obtain retatrutide
We do not sell, supply, source, import, prescribe, or broker retatrutide or any other medication, and we do not refer visitors to anyone who does.
Specifically, we do not:
- maintain a waiting list, interest list, or availability notification list of any kind;
- publish or track pricing, suppliers, vendors, pharmacies, or sources;
- accept payment from visitors for anything;
- run clinical trials or enroll participants in them.
Our newsletter is used only to notify subscribers when we publish or update articles on this Site.
If you are looking for a clinical trial, ClinicalTrials.gov is the appropriate public registry.
6. Accuracy and currency of information
Medical and scientific information changes. Trial results are revised, new safety data emerges, and published analyses are superseded by later work.
We make reasonable efforts to keep our content accurate and current, but we do not warrant that any information on this Site is accurate, complete, or up to date. Content may become outdated between updates and may be changed without notice. Each article carries its own publication or update date.
7. Trial results do not predict individual outcomes
Results reported in clinical trials are averages across study populations under controlled conditions. Individual responses to any medication vary widely, depending on genetics, baseline health, concurrent medications, adherence, and many other factors.
Any figure we cite from published research describes the study population it came from, and nothing more.
8. Risks and side effects
All medications carry risks. Any description of side effects on this Site is drawn from published trial data, may be incomplete, and may change as further data becomes available. It is not a substitute for the safety information that a prescriber and a pharmacist provide for an approved medication.
If you experience side effects from any medication, contact your healthcare provider. Serious side effects can be reported to the FDA through MedWatch at fda.gov/medwatch or 1-800-FDA-1088.
9. Mental health
Medications in this class have been studied for possible effects on mood and behavior, and this remains an area of ongoing research.
If you experience depression, anxiety, marked changes in mood, or thoughts of self-harm, contact your healthcare provider. In the United States, the 988 Suicide & Crisis Lifeline can be reached by call or text at 988.
10. Medical emergencies
If you think you may be having a medical emergency, call 911 or your local emergency number immediately. Do not rely on this Site in an emergency, and do not delay seeking care in order to look something up here.
Poison Control (United States): 1-800-222-1222.
11. Third-party information and links
This Site cites and links to external sources, including published research, regulatory materials, and news coverage. We do not control those sources and are not responsible for their content, for changes made to them after we link to them, or for any information or advice they provide. A link is not an endorsement.
12. Geographic scope
Our content is written primarily with reference to United States regulatory processes and to research published in English. Regulatory status, availability, and prescribing information differ between countries. If you are outside the United States, consult your local healthcare authority.
13. Limitation of liability
TO THE MAXIMUM EXTENT PERMITTED BY LAW, RETAWEIGHTLOSS.COM AND ITS OPERATORS AND CONTRIBUTORS SHALL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES ARISING FROM YOUR USE OF THIS SITE OR FROM ANY DECISION MADE ON THE BASIS OF INFORMATION PUBLISHED HERE, INCLUDING ANY HEALTH OUTCOME. OUR TOTAL LIABILITY FOR ALL CLAIMS SHALL NOT EXCEED ONE HUNDRED U.S. DOLLARS ($100).
You are responsible for evaluating the information published on this Site and for the decisions you make about your own health.
14. Changes to this disclaimer
We may update this disclaimer from time to time. Changes take effect when posted, and the "Last updated" date at the top of this page will reflect them.
15. Contact
Questions about this disclaimer or about our published content: retaweightloss.contact@gmail.com
We cannot answer medical questions, and we cannot assist with obtaining any medication. For medical questions, please consult your healthcare provider.
Emergency resources (United States)
Medical emergency: 911
Poison Control: 1-800-222-1222
988 Suicide & Crisis Lifeline: call or text 988
FDA MedWatch (report side effects): fda.gov/medwatch or 1-800-FDA-1088